Company profile CELU

Celularity Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 18:24:50.

After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0.
Celularity expected interest is significantly lower compared to previous quarter (-51.7%) and same quarter last year (-77.0%).

YearQ1Q2Q3Q4
201959
133
125.4% QoQ
92
-30.8% QoQ
67
-27.2% QoQ
2020 265
349.2% YoY 295.5% QoQ
252
89.5% YoY -4.9% QoQ
186
102.2% YoY -26.2% QoQ
164
144.8% YoY -11.8% QoQ
2021 218
-17.7% YoY 32.9% QoQ
183
-27.4% YoY -16.1% QoQ
406
118.3% YoY 121.9% QoQ
202
23.2% YoY -50.2% QoQ
2022 303
39.0% YoY 50.0% QoQ
297
62.3% YoY -2.0% QoQ
241
-40.6% YoY -18.9% QoQ
124
-38.6% YoY -48.5% QoQ
2023 305
0.7% YoY 146.0% QoQ
181
-39.1% YoY -40.7% QoQ
195
-19.1% YoY 7.7% QoQ
145
16.9% YoY -25.6% QoQ
2024 30
-90.2% YoY -79.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Celularity search interestLast update: February 08 2024 18:24:49.
Correlation coefficient between keyword and revenue is 0.13
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:24:50.

The average 5 years interest of Celularity was 15.51 per week.
The last year interest of Celularity compared to the last 5 years has changed by -12.57%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 79.84%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Celularity cell therapy to provide analysis

Correlation between past revenue and Celularity cell therapy search interest

There is not enough data for Celularity cell therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Celularity cell therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CYCART-19 to provide analysis

Correlation between past revenue and CYCART-19 search interest

There is not enough data for CYCART-19 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CYCART-19 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:24:39.

After 39 days of this quarter the interest is at 125.0. Based on that we can calculate that during remaining 52 days it will total up to 292.0.
CYNK-001 expected interest is significantly higher compared to same quarter last year (+228.1%) but similar to previous quarter.

YearQ1Q2Q3Q4
201965
67
3.1% QoQ
56
-16.4% QoQ
53
-5.4% QoQ
2020 11
-83.1% YoY -79.2% QoQ
75
11.9% YoY 581.8% QoQ
79
41.1% YoY 5.3% QoQ
41
-22.6% YoY -48.1% QoQ
2021 51
363.6% YoY 24.4% QoQ
103
37.3% YoY 102.0% QoQ
86
8.9% YoY -16.5% QoQ
0
-100.0% YoY -100.0% QoQ
2022 20
-60.8% YoY inf% QoQ
0
-100.0% YoY -100.0% QoQ
13
-84.9% YoY inf% QoQ
99
inf% YoY 661.5% QoQ
2023 89
345.0% YoY -10.1% QoQ
61
inf% YoY -31.5% QoQ
36
176.9% YoY -41.0% QoQ
214
116.2% YoY 494.4% QoQ
2024 125
40.4% YoY -41.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and CYNK-001 search interestLast update: February 08 2024 18:24:38.
Correlation coefficient between keyword and revenue is 0.01
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:24:40.

The average 5 years interest of CYNK-001 was 5.15 per week.
The last year interest of CYNK-001 compared to the last 5 years has changed by 90.87%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 112.31%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for APPL-001 to provide analysis

Correlation between past revenue and APPL-001 search interest

There is not enough data for APPL-001 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for APPL-001 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Celularity stem cells to provide analysis

Correlation between past revenue and Celularity stem cells search interest

There is not enough data for Celularity stem cells to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Celularity stem cells to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Celularity surgical products to provide analysis

Correlation between past revenue and Celularity surgical products search interest

There is not enough data for Celularity surgical products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Celularity surgical products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:24:56.

After 39 days of this quarter the interest is at 62.0. Based on that we can calculate that during remaining 52 days it will total up to 145.0.
Celularity stock price expected interest is significantly higher compared to same quarter last year (+130.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
20190
73
inf% QoQ
119
63.0% QoQ
118
-0.8% QoQ
2020 207
inf% YoY 75.4% QoQ
57
-21.9% YoY -72.5% QoQ
30
-74.8% YoY -47.4% QoQ
181
53.4% YoY 503.3% QoQ
2021 102
-50.7% YoY -43.6% QoQ
92
61.4% YoY -9.8% QoQ
198
560.0% YoY 115.2% QoQ
80
-55.8% YoY -59.6% QoQ
2022 165
61.8% YoY 106.2% QoQ
194
110.9% YoY 17.6% QoQ
186
-6.1% YoY -4.1% QoQ
96
20.0% YoY -48.4% QoQ
2023 63
-61.8% YoY -34.4% QoQ
57
-70.6% YoY -9.5% QoQ
142
-23.7% YoY 149.1% QoQ
163
69.8% YoY 14.8% QoQ
2024 62
-1.6% YoY -62.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Celularity stock price search interestLast update: February 08 2024 18:24:55.
Correlation coefficient between keyword and revenue is 0.45
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:24:56.

The average 5 years interest of Celularity stock price was 9.14 per week.
The last year interest of Celularity stock price compared to the last 5 years has changed by -6.56%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 27.65%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Celularity CEO to provide analysis

Correlation between past revenue and Celularity CEO search interest

There is not enough data for Celularity CEO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Celularity CEO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Celularity clinical trials to provide analysis

Correlation between past revenue and Celularity clinical trials search interest

There is not enough data for Celularity clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Celularity clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CELU
Earnings date: 2024-03-29 After close
Company name: Celularity Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-01T20:30:00Z

GlobeNewswire
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

2026-04-27T13:00:00Z

GlobeNewswire
NEXGEL Appoints Ian Blackman as Chief Financial Officer

2026-04-21T13:00:00Z

GlobeNewswire
NEXGEL New Strategic Partner, Sequence LifeScienceā„¢, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment

2026-04-21T12:30:00Z

GlobeNewswire
Celularity Announces Closing of Transaction with NexGel

2026-04-17T20:35:00Z

GlobeNewswire
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

2026-03-12T12:45:00Z

GlobeNewswire
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-03-12T12:30:00Z

GlobeNewswire
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

2026-03-10T12:45:00Z

GlobeNewswire
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-03-10T12:30:00Z

GlobeNewswire
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

2026-02-10T13:30:00Z

GlobeNewswire
Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

2025-12-26T13:30:00Z

GlobeNewswire
Celularity CEO Comments on Centers for Medicare & Medicaid Services' Withdrawal of Skin Substitute Local Coverage Determinations

2025-12-22T21:01:00Z

GlobeNewswire
Celularity Announces Closing of Financing Transactions

2025-12-18T19:10:00Z

GlobeNewswire
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision

2025-10-30T12:00:00Z

GlobeNewswire
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care

2025-10-14T12:45:00Z

GlobeNewswire
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease